Temsirolimus (CCI-779)
Home > D. General pathology > Therapy, Toxics and drugs
Therapy, Toxics and drugs
-
temsirolimus
9 December 2007 -
alcoholism
12 October 2007alcohol abuse
-
aflatoxin-M1
1 August 2007aflatoxin M1
-
BPDE
18 July 2007Benzo[a]pyrene diol epoxide ((+)-7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene) (BPDE) is the carcinogenic product of three enzymatic reactions.
See also
benzo[a]pyrene
BPDE-DNA adducts -
curcuminoids
18 July 2007Types
curcumin (U1)
tetrahydrocurcumin (THU1)
References
Osawa T. Nephroprotective and hepatoprotective effects of curcuminoids. Adv Exp Med Biol. 2007;595:407-23. PMID: #17569222# -
selective oestrogen-receptor modulators
8 July 2007SORM
-
anti-tubulin agents
8 July 2007References
Jackson JR, Patrick DR, Dar MM, Huang PS. Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat Rev Cancer. 2007 Feb;7(2):107-17. PMID: #17251917# -
anti-mitotic therapies
8 July 2007References
Jackson JR, Patrick DR, Dar MM, Huang PS. Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat Rev Cancer. 2007 Feb;7(2):107-17. PMID: #17251917# -
phase 0 trials
8 July 2007References
Kummar S, Kinders R, Rubinstein L, Parchment RE, Murgo AJ, Collins J, Pickeral O, Low J, Steinberg SM, Gutierrez M, Yang S, Helman L, Wiltrout R, Tomaszewski JE, Doroshow JH. Compressing drug development timelines in oncology using phase ’0’ trials. Nat Rev Cancer. 2007 Feb;7(2):131-9. PMID: #17251919# -
rexinoids
5 July 2007References
Liby KT, Yore MM, Sporn MB. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer. 2007 May;7(5):357-69. PMID: #17446857#
0 | ... | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90 | 100 | ... | 170